RAD51 and breast carcinoma: Increased levels of the kinase ataxia telangiectasia mutated (ATM), which mediate the HR pathway, were found in chemoresistant breast cancer cells [23], and cisplatin treatment was associated with increased expression of the DSB repair protein RAD51, inducing chemoresistance in breast cancer cells [24].